搜尋
VolitionRX Ltd
VNRX添加自選
1.400USD
+0.020+1.47%
收盤 07/02, 13:00（美東）報價延遲15分鐘
555.14K總市值
虧損本益比TTM
關於 VolitionRX Ltd 公司
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRX Ltd簡介
公司代碼VNRX
公司名稱VolitionRX Ltd
上市日期Feb 06, 2015
CEOButera (Salvatore Thomas)
員工數量85
證券類型Ordinary Share
年結日Feb 06
公司地址1489 West Warm Springs Road
城市HENDERSON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編89014
電話17024251561
網址https://volition.com/
公司代碼VNRX
上市日期Feb 06, 2015
CEOButera (Salvatore Thomas)
VolitionRX Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
170.16K
--
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.36K
--
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
31.97K
+31.59%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
31.19K
-0.85%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
21.20K
+40.80%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
20.68K
+8.40%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
18.19K
-3.54%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
16.56K
-2.28%
Mr. Rodney Gerard Rootsaert
Mr. Rodney Gerard Rootsaert
Corporate Secretary
Corporate Secretary
13.70K
-2.65%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
12.24K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
170.16K
--
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.36K
--
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
31.97K
+31.59%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
31.19K
-0.85%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
21.20K
+40.80%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
20.68K
+8.40%
常見問題
VolitionRX Ltd的前五大股東是誰？
VolitionRX Ltd的前五大股東如下：Mr. Guy Archibald Innes
有多少機構持有VolitionRX Ltd(VNRX)的股份？
截至2026Q1，共有66家機構持有VolitionRX Ltd的股份，合計持有的股份價值約為1.13M，占公司總股份的13.93% 。與2025Q4相比，機構持股有所增加，增幅為-209799.00。